Groowe Groowe / Newsroom / AZN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AZN News

AstraZeneca PLC

House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English

prnewswire.com
ALKS STG GSK SNY TEVA AZN INCY REGN PFE BMY LLY AMGN ABBV GILD BIIB CSL VRTX BHC NVS MRK LEO ALLT CNTB INM

Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy, Ph.D. as Chief Scientific Officer

businesswire.com
LLY AZN XCUR

Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences USA - English APAC - English USA - English

prnewswire.com
AZN

Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences USA - English APAC - English USA - English

prnewswire.com
AZN

HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet

globenewswire.com
HCM AZN

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

businesswire.com
PFE AZN UMBF CLLS REGN

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

globenewswire.com
JNJ BIIB NVS VTRS RPRX ABBV AZN MRK RIGL GSK REGN GILD AMGN LLY BMY XBI IBB

Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale

businesswire.com
AZN

Biomedical and ICT Convergence Market Research Report 2025-2030: Outlook for Various Biomedical Products, Services, and Solutions Poised to Benefit from Various IT and Telecom Technologies - ResearchAndMarkets.com

businesswire.com
ABT AMGN ADI AZN BIIB BIO XRAY GEHC GILD HON JNJ MD MRK NVDA NOVT NVO NXPI PFE SMCI SOXX TE TXN TMO WMT ZBH

Radiopharmaceuticals Market to Worth Over US$ 13.4 Billion by 2033 | Astute Analytica

globenewswire.com
BMY AZN LLY NVS MRK JNJ